What Imago BioSciences, Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 0 | 0 |
| Total trades | 0 | 0 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 0 |
| Disposed | 0 | 0 |
| Net activity | +0 | +0 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Baltera Robert Jr. | Director | Jan 11 | Tender Offer · U | −850 | $36.00 | −$30.6K | 0 |
| Henner Dennis | Director | Jan 11 | Tender Offer · U | −26,095 | $36.00 | −$939K | 0 |
| Peppe Jennifer | See Remarks | Jan 11 | Tender Offer · U | −150,188 | $36.00 | −$5.41M | 0 |
| Rienhoff Hugh Jr | Chief Executive Officer | Jan 11 | Tender Offer · U | −501,702 | $36.00 | −$18.1M | 0 |
| Tapper Amy E. | Chief, Technical Operations | Jan 11 | Tender Offer · U | −141,094 | $36.00 | −$5.08M | 0 |
| Chiang Hsiangyi | Senior Vice President, Finance | Jan 11 | Tender Offer · U | −26,538 | $36.00 | −$955K | 0 |
| Arenberg Michael | See Remarks | Jan 11 | Tender Offer · U | −51,532 | $36.00 | −$1.86M | 0 |
| Eichorn Laura G. | Chief Financial Officer | Jan 11 | Tender Offer · U | +246,453 | $36.00 | +$8.87M | 0 |
| Chiang Hsiangyi | Senior Vice President Finance | Jan 04 | Exercise / conversion · M | +19,941 | $4.20 | +$83.8K | 26,538 |
| Rienhoff Hugh Jr | Chief Executive Officer | Jan 03 | Exercise / conversion · M | +7,415 | $2.52 | +$18.7K | 501,702 |
| Rienhoff Hugh Jr | Chief Executive Officer | Jan 03 | Exercise / conversion · M | +4,761 | $2.52 | +$12K | 494,287 |
| Tapper Amy E. | See Remarks | Jan 03 | Exercise / conversion · M | +1,379 | $22.76 | +$31.4K | 141,094 |
| Tapper Amy E. | See Remarks | Jan 03 | Exercise / conversion · M | +12,400 | $4.20 | +$52.1K | 139,715 |
| Tapper Amy E. | See Remarks | Jan 03 | Exercise / conversion · M | +7,482 | $2.52 | +$18.9K | 127,315 |
| Arenberg Michael | See Remarks | Jan 03 | Exercise / conversion · M | +2,145 | $15.45 | +$33.1K | 51,532 |
| Eichorn Laura G. | Chief Financial Officer | Jan 03 | Exercise / conversion · M | +1,769 | $22.76 | +$40.3K | 246,453 |
| Eichorn Laura G. | Chief Financial Officer | Jan 03 | Exercise / conversion · M | +12,400 | $4.20 | +$52.1K | 244,684 |
| Eichorn Laura G. | Chief Financial Officer | Jan 03 | Exercise / conversion · M | +22,950 | $2.52 | +$57.8K | 232,284 |
| Peppe Jennifer | See Remarks | Jan 03 | Exercise / conversion · M | +1,379 | $22.76 | +$31.4K | 150,188 |
| Eichorn Laura G. | Chief Financial Officer | Dec 27 | Open-market sale · S | −3,100 | $35.93 | −$111K | 207,737 |
Loading...
